's degree in life science. Minimum 5 years of recent experience as a ClinicalResearchAssociate with at least 2 years... dynamic and multicultural work environment? Are you passionate about clinicalresearch and have previous experience in people...
of recent experience as a ClinicalResearchAssociate with at least 2 years of experience of leading CRAs. Fluent in written...? Are you passionate about clinicalresearch and have previous experience in people management? If yes, you might be our new Clinical...
future of clinical development. As a Senior ClinicalResearchAssociate, you will be partnering with a biotech company...Overview ICON plc is a world-leading healthcare intelligence and clinicalresearch organization. We’re proud...
Junior, ClinicalResearchAssociate, CZ Republic IQVIA CZ Republic is looking for talented and motivated team member... scientific discipline or health care Experience as a ClinicalResearch Associated for almost two years. Very good computer...
About Us: Nucs AI is a leading-edge MedTech startup focused on transforming the clinical management of prostate... patient outcomes and streamline clinical workflows. We are searching for a passionate and ambitious individual...
Following the company's performance for the September quarter, analysts have remained cautious about Elcid Investments stock due to its low liquidity in the market. The company's average trading volume on both the BSE and NSE is around 1,000 shares. Continue Reading »
Gold prices are showing signs of recovery after a sharp drop, with recent gains linked to a pause in the dollar's rally. Currently priced at ₹75,585 per 10 grams, the market offers a strategic entry point for buyers, especially during the wedding season. Continue Reading »
UPL plans to raise ₹3,377.74 crore via a rights issue of 9.38 crore partly paid shares at ₹360 each. The issue ratio is 1:8, with the record date set for November 26, 2024. Shareholders can subscribe, sell rights, or ignore the offer. Continue Reading »
Delhivery reported profitability for the second consecutive quarter, with a profit after tax of ₹10 crore in Q2 FY25 as compared to a net loss of ₹103 crore in Q2 FY24. Following the company's Q2 numbers, domestic brokerage firm Elara Capital retained its 'buy' rating on the stock. Continue Reading »
India's long-term growth prospects remain strong, according to JM Financial. Amid recent market volatility, the firm recommends evaluating stocks with strong fundamentals across market capitalisations for potential recovery. Continue Reading »
Upcoming IPO: CIEL HR Services Ltd has submitted its draft red herring prospectus for an IPO with SEBI. The company offers technology-driven HR solutions and plans to raise funds for corporate purposes and acquisitions. Continue Reading »
Indian investors are facing challenges as equities and gold selloff, with Nifty 50 down 10.5% and gold down 5.3%. Economic uncertainty, weak corporate earnings, and geopolitical tensions are dampening sentiment. Continue Reading »